|
García Garre E, Luengo Gil G, Montoro García S, Gonzalez Billalabeitia E, Zafra Poves M, García Martinez E, Roldán Schilling V, Navarro Manzano E, Ivars Rubio A, Lip GYH, Ayala de la Peña F. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. Breast Cancer Res Treat. 2018 May;169(1):83-92. doi: 10.1007/s10549-017-4656-z. Epub 2018 Jan 16. PubMed PMID: 29340882.
AÑO: 2018; IF: 4.624
|
29340882
|
Luengo-Gil G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, Chaves-Benito A, Garcia-Martinez E, Garcia-Garre E, Vicente V, Ayala de la Peña F. Angiogenic role of miR-20a in breast cancer. PLoS One. 2018 Apr 4;13(4):e0194638. doi: 10.1371/journal.pone.0194638. eCollection 2018. PubMed PMID: 29617404; PubMed Central PMCID: PMC5884522.
AÑO: 2018; IF: 2.776
|
|
Carmona-Bayonas A, Sánchez-Cánovas M, Plasencia JM, Custodio A, Martínez de Castro E, Virizuela JA, Ayala de la Peña F, Jiménez-Fonseca P. Key points to optimizing management and research on cancer-associated thrombosis. Clin Transl Oncol. 2018 Feb;20(2):119-126. doi: 10.1007/s12094-017-1692-4. Epub 2017 Jun 7. Review. PubMed PMID: 28593335.
AÑO: 2018; IF: 2.441
|
|
Otero MJ, Vera R, González-Pérez C, Ayala de la Peña F, Peñuelas Á, Quer N. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Farm Hosp. 2018 Nov 1;42(6):261-268. doi: 10.7399/fh.11132. PubMed PMID: 30381047.
AÑO: 2018
|
|
Gabaldó Barrios X, Sarabia Meseguer MD, Marín Vera M, Sánchez Bermúdez AI, Macías Cerrolaza JA, Sánchez Henarejos P, Zafra Poves M, García Hernández MR, Cuevas Tortosa E, Aliaga Baño Á, Castillo Guardiola V, Martínez Hernández P, Tovar Zapata I, Martínez Barba E, Ayala de la Peña F, Alonso Romero JL, Noguera Velasco JA, Ruiz Espejo F. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x. PubMed PMID: 28477318.
AÑO: 2017; IF: 1.943
|